BioMerieux Recalls VIDAS 3 Software Version 1.1.4 Due to Anomalies
BioMerieux SA is recalling 1,161 units of VIDAS 3 software version 1.1.4 in the U.S. because anomalies identified during the development of version 1.2 were found to be present in the current field version.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: The recall is classified as FDA Class II, and the source text does not report any illnesses, injuries, or deaths. The hazard is described as 'anomalies' without specific details of harm, fitting the criteria for a moderate severity recall involving a potential defect without reported adverse health consequences.
Plain-English summary
BioMerieux SA is recalling 1,161 units of VIDAS 3 software version 1.1.4 distributed in the United States. The recall is associated with reference number #412590 and software version 1.1.4.
The recall was initiated because anomalies were identified during the development of VIDAS 3 software version 1.2. These anomalies were observed to be already present in the current software version, VIDAS 3 version 1.1.4, which is available in the field. The source text does not specify the nature of the anomalies or any reported adverse events, injuries, or illnesses.
Users of the affected software should contact BioMerieux SA for further instructions regarding the recall and potential software updates or replacements.
The recalled product
- Product
- VIDAS 3 software v. 1.1.4
- Manufacturer
- BioMerieux SA
- Hazard
- Affected units
- 1,161
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- REF: #412590
- Lot: Software version 1.1.4
Distribution
Distribution scope not specified by the agency.
Related recalls
Same manufacturer · BioMerieux SA
See all →- HighMYLA Diagnostic System Software Versions Recalled for Risk of False Negatives
FDA (Devices) · 2021-10-20
- HighMYLA Laboratory Software: Potential Test Result Alteration from Software Anomaly
FDA (Devices) · 2021-08-18
- ModerateBioMerieux NucliSENS Magnetic Extraction Reagents Recalled Due to Temperature Exposure
FDA (Devices) · 2018-10-31
- ModerateBioMerieux Recalls VIDAS FSH Assay Kits Due to Calibration Issues
FDA (Devices) · 2018-07-04
- ModerateBioMérieux PREVI Color Gram Reagents Recalled Due to Temperature Excursion
FDA (Devices) · 2018-06-20
Same hazard · software defect
See all →- HighMidmark IQecg Digital ECG Software Recall for Inaccurate Waveforms
FDA (Devices) · 2026-09-02
- HighMidmark Digital ECG Software Recall for Incorrect Waveform Display
FDA (Devices) · 2026-09-02
- ModerateEndoFLIP System Recall Due to Incorrect Catheter Expiration Flags
FDA (Devices) · 2026-08-26
- HighBeckman Coulter DxC 500i Analyzer Modules Recalled for Software Defect
FDA (Devices) · 2026-08-26
- HighMitsubishi Recalls Outlander Models for Rearview Camera Software Defect
NHTSA · 2026-08-25